Covestor
INBX icon

Covestor’s Inhibrx INBX Stock Holding History

Covestor’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$0 Sell
2
-1
-33% -$100 ﹤0.01% 2591
2026
Q2 		$0 Buy
3
+2
+200% +$200 ﹤0.01% 2649
2026
Q1 		$0 Buy
+1
New +$74 ﹤0.01% 2507
2024
Q4 		– Sell
-1,666
Closed -$26K – 2468
2024
Q3 		$26K Buy
+1,666
New +$23.4K 0.02% 1121

Other funds holding INBX

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Ethic Inc
Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Covestor's INBX Position: Q3 2026 in Review

Covestor reduced its Inhibrx (INBX) stake by 33% in Q3 2026, selling an estimated $100 and leaving 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

Covestor first reported a position in INBX in Q3 2024 and has held it in 4 quarters since. The position peaked at $26K in Q3 2024. 50 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Covestor held 2 shares of Inhibrx worth $0 as of Q3 2026.
  • Covestor sold 1 Inhibrx share in Q3 2026, an estimated $100.
  • Inhibrx made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2591 holding.
  • Covestor first reported a position in Inhibrx in Q3 2024 and has held it in 4 quarters since.
  • Covestor's Inhibrx position peaked at $26K in Q3 2024.
  • 50 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.